Foundation Consumer Brands Acquires Seven OTC Brands from GlaxoSmithKline

October 1, 2020

Foundation Consumer Brands (backed by Juggernaut Capital Partners and Kelso & Company) acquired a portfolio of seven over-the-counter (OTC) brands from GlaxoSmithKline Consumer Healthcare. The transaction transfers brands including Breathe Right and Children's Dimetapp into a new PE-backed OTC platform (Foundation Consumer Brands), which will leverage existing management and distribution relationships with Foundation Consumer Healthcare and Ceuta Healthcare Group to drive growth.

Buyers
Foundation Consumer Brands, Juggernaut Capital Partners, Kelso & Company (Kelso Fund X)
Targets
Breathe Right Nasal Strips, Children's Dimetapp, Anbesol, Alavert, Dristan, Primatene Tablets, FiberCon
Sellers
GlaxoSmithKline Consumer Healthcare
Platforms
Foundation Consumer Brands
Industry
Pharmaceuticals
Location
United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.